Oxford Square Capital - 5.50% NT REDEEM 31/07/2028 USD 25 OverviewOxford Square Capital - 5.50% NT REDEEM 31/07/2028 USD 25's EBIT is $-26M, below the Finance sector average of $300B.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026
As of the most recent data (March 2026), OXSQG shows a EBIT of $-26M. That compares with $2.1M in the prior-year period — down 1308.7% year over year. That is below the Finance sector average of $300B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, OXSQG's EBIT is now $-26M (was $2.1M) — a 1308.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Oxford Square Capital - 5.50% NT REDEEM 31/07/2028 USD 25 is outperforming or lagging.
The Finance sector average EBIT is about $300B. Oxford Square Capital - 5.50% NT REDEEM 31/07/2028 USD 25 is at $-26M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how OXSQG stacks up against individual peers as well.
Tracking OXSQG's ebit over time shows whether Oxford Square Capital - 5.50% NT REDEEM 31/07/2028 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $-26M That compares with $2.1M in the prior-year period — down 1308.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Oxford Square Capital - 5.50% NT REDEEM 31/07/2028 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-26M) with ownership activity and broader fundamentals.
